Top Markets
Coin of the day
Arvee Laboratories (India) Ltd. Arvee Laboratories (India) Ltd.

Arvee Laboratories (India) Ltd.

ARVEE
Rank in Stocks #29514
Arvee Laboratories (India) Ltd., established in 2012 and headquartered in... Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. Additionally, Arvee Laboratories manufactures intermediates critical for contrast media, supplying compounds like 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. The firm also provides drug intermediates, specifically 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-amino pyridine, and 2-chloro-5-nitrobenzoic acid. Beyond its domestic sales, Arvee Laboratories actively exports its chemical products.
Share Price
$1.89
Market Cap
$20.83M
Change (1 day)
0.44%
Change (1 year)
2.38%
Country
IN
Trade Arvee Laboratories (India) Ltd. (ARVEE)
Revenue for Arvee Laboratories (India) Ltd. (ARVEE)
Revenue in Aug 2026 TTM: 0
According to Arvee Laboratories (India) Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Arvee Laboratories (India) Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$35.45B -
GB
- -
FR
$24.41B -
US
$16.84B -
US
$12.60B -
US